Future-proofing your pharmacovigilance delivery model: Achieving scalability and cost effectiveness with AI/Smart Machines

Oct 25, 2017

Register Free: http://www.appliedclinicaltrialsonline.com/act_w/smart

With increasing numbers of safety data sources and adverse event reports, drug developers are moving past manual processes and seeking more efficient, cost-saving measures to manage pharmacovigilance. By leveraging artificial intelligence and automation, companies can address the growing volumes without sacrificing quality or compliance, thereby sustaining the safety integrity of their products.

Attend this live webinar to learn the advantages of leveraging AI and automation in your pharmacovigilance strategy.

Key takeaways:

  • How ICSR challenges can be met with automation
  • Solutions for reducing manually reviewed AE records by 70%
  • How AI/Smart Machines play an essential role in scaling PV operations for the future



Annette Williams, R.Ph,, Vice President, Pharmacovigilance, QuintilesIMS

Siva Nadarajah, General Manager, Big Data and Compliance, QuintilesIMS


Date and Time:

Live: Tuesday, Oct. 25, 2017 | 11 am EDT

After the final airing of the webcast Oct. 25, 2017 it will be available on demand until Oct. 25, 2018. 

Sponsor: QuintilesIMS

Register Free: http://www.appliedclinicaltrialsonline.com/act_w/smart

lorem ipsum